HHS should protect payments to clinical trial participants

The HHS Office of Inspector General is seeking public comment on whether to protect payments to clinical trial participants. Research shows that compensating individuals, including those who use drugs, is essential for developing effective medical treatments. The agency is gathering input on this issue to inform potential policy changes.